Diagnos Stock Market Value
| DGNOF Stock | USD 0.22 0.01 4.35% |
| Symbol | DIAGNOS |
DIAGNOS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DIAGNOS's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DIAGNOS.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in DIAGNOS on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding DIAGNOS or generate 0.0% return on investment in DIAGNOS over 90 days. DIAGNOS is related to or competes with Marpai, Starpharma Holdings, BioMark Diagnostics, Celyad Oncology, and Positron Corp. DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Ara... More
DIAGNOS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DIAGNOS's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DIAGNOS upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.47 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 21.2 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 8.33 |
DIAGNOS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DIAGNOS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DIAGNOS's standard deviation. In reality, there are many statistical measures that can use DIAGNOS historical prices to predict the future DIAGNOS's volatility.| Risk Adjusted Performance | 0.0106 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0056 |
DIAGNOS February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0106 | |||
| Market Risk Adjusted Performance | 0.0156 | |||
| Mean Deviation | 2.7 | |||
| Semi Deviation | 3.22 | |||
| Downside Deviation | 5.47 | |||
| Coefficient Of Variation | 29769.02 | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.41 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0056 | |||
| Maximum Drawdown | 21.2 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 8.33 | |||
| Downside Variance | 29.94 | |||
| Semi Variance | 10.37 | |||
| Expected Short fall | (5.59) | |||
| Skewness | 0.0393 | |||
| Kurtosis | 0.8048 |
DIAGNOS Backtested Returns
At this point, DIAGNOS is out of control. DIAGNOS retains Efficiency (Sharpe Ratio) of 0.0387, which denotes the company had a 0.0387 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for DIAGNOS, which you can use to evaluate the volatility of the firm. Please confirm DIAGNOS's Coefficient Of Variation of 29769.02, market risk adjusted performance of 0.0156, and Downside Deviation of 5.47 to check if the risk estimate we provide is consistent with the expected return of 0.14%. DIAGNOS has a performance score of 3 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.64, which means possible diversification benefits within a given portfolio. As returns on the market increase, DIAGNOS's returns are expected to increase less than the market. However, during the bear market, the loss of holding DIAGNOS is expected to be smaller as well. DIAGNOS at this moment owns a risk of 3.62%. Please confirm DIAGNOS value at risk, day median price, and the relationship between the total risk alpha and expected short fall , to decide if DIAGNOS will be following its current price history.
Auto-correlation | -0.77 |
Almost perfect reverse predictability
DIAGNOS has almost perfect reverse predictability. Overlapping area represents the amount of predictability between DIAGNOS time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DIAGNOS price movement. The serial correlation of -0.77 indicates that around 77.0% of current DIAGNOS price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.77 | |
| Spearman Rank Test | -0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Other Information on Investing in DIAGNOS OTC Stock
DIAGNOS financial ratios help investors to determine whether DIAGNOS OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DIAGNOS with respect to the benefits of owning DIAGNOS security.